Comparing treatments for acute atrial fibrillation and flutter
Official title: Acute Atrial Fibrillation and Flutter Treated Electively - A Randomized Controlled Clinical Trial on the Safety of Elective Management of Acute Atrial Fibrillation and Flutter
Run by Tampere University · NCT04267159 · Data updated 2026-11-12
This study is testing two different ways to treat people with sudden atrial fibrillation or flutter in the emergency room to see if a less immediate approach can be done safely.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Tampere University Academic / other |
| Locations | 4 sites (Jyväskylä, Central Finland and 3 other locations) |
| Status | Recruiting |
| Started | February 10, 2020 |
| Main results expected | June 2027 |
| Study ends | June 2029 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT04267159 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients presenting with acute atrial fibrillation or flutter within 48 hours who are in good clinical condition.
✕Probably not a fit
Patients with hemodynamic instability or other major acute illnesses may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The AFFELECT study evaluates two treatment approaches for patients with acute atrial fibrillation or flutter who require rhythm control. Patients presenting to the emergency department will be randomly assigned to either conventional care, which involves immediate cardioversion, or elective care, where they are discharged after temporary rhythm control is achieved. Follow-up visits with a cardiologist will occur approximately one week after the emergency room visit to assess the effectiveness of the treatment. The goal is to determine if elective treatment can be safely implemented within a short timeframe.
Why it matters
Potential benefit: If successful, this study could provide a safer and more efficient treatment option for patients with acute atrial fibrillation and flutter.
How similar studies have gone: While there have been studies on rhythm control in atrial fibrillation, this specific approach of elective treatment within a short timeframe is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients presenting with acute (\<48hours) atrial fibrillation or atrial flutter to ER * Planned acute rhythm control for the arrhythmia by the attending physician in ER * Good perceived health as assessed by attending physician in ER * Resting heart rate 110bpm or lower before or after adequate rate control therapy Exclusion Criteria: * Haemodynamically stable (mean arterial pressure above 60mmHg) * Need for acute restoration of sinus rhythm due to some other somatic cause * No other major complicating acute illness (e.g. decompensated HF or acute MI) * Anticoagulation not safe * Mechanical heart valve or mitral stenosis * The need for prolonged (\>24h) hospitalization due to any cause * Exceptionally high risk for thromboembolic events (e.g. history of thromboembolic stroke regardless of adequate anticoagulation) * Transesophageal echocardiography contraindicated
Where it's running
-
Central Finland Central Hospital
Jyväskylä, Central Finland, Finland Recruiting -
Kanta-Häme Central Hospital
Hämeenlinna, Kanta-Häme, Finland Recruiting -
Tampere University Hospital
Tampere, Pirkanmaa, Finland Recruiting -
Päijät-Häme Central Hospital
Lahti, Paijat-Hame Region, Finland Not yet recruiting
Study contacts
- Principal investigator: Jussi A Hernesniemi, MD, PhD — TAYS Heart Hospital and Tampere University
- Study coordinator: Jussi A Hernesniemi, MD, PhD
- Email: jussi.hernesniemi@sydansairaala.fi
- Phone: 31164254
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HeartBeam ECG Registry: See How Heartbeat Patterns Look Across People
This registry tests HeartBeam ECG recordings in real-world patients to build a de-identified database for research.
-
Using the VERAFEYE imaging and navigation system to guide catheter ablation for atrial arrhythmias
This study will try the VERAFEYE imaging and guidance system during catheter ablation in adults with atrial flutter or atrial fibrillation to see if it integrates well with standard procedures.
-
Anatomical navigation to guide catheter ablation for atrial fibrillation and flutter
This trial will test whether the VERAFEYE Anatomical Guidance System helps doctors guide catheter ablation in adults with atrial fibrillation or atrial flutter.
-
Monitoring heart rhythm after noncardiac surgery
This study is testing if wearing a portable heart monitor for up to 14 days after noncardiac surgery can help find heart rhythm problems that are often missed, to improve care for patients.
-
Surgical procedure to prevent heart rhythm issues after cardiac surgery
This study is testing a surgical procedure to see if it can help prevent heart rhythm problems after heart surgery for patients who haven't had these issues before.
-
Registry for Atrial Fibrillation Care Guidelines
This study is tracking how well hospitals are treating patients with Atrial Fibrillation to make sure they get the best care possible.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.